Fukushi-Irié M, Ito M, Amaya Y, Amizuka N, Ozawa H, Omura S, Ikehara Y, Oda K
Department of Oral Biochemistry, Faculty of Dentistry, Niigata University, Gakkocho-dori, Niigata 951-8514, Japan.
Biochem J. 2000 Jun 15;348 Pt 3(Pt 3):633-42.
Tissue-non-specific alkaline phosphatase (TNSALP) with an Arg(54)-->Cys (R54C) or an Asp(277)-->Ala (D277A)substitution was found in a patient with hypophosphatasia [Henthorn,Raducha, Fedde, Lafferty and Whyte (1992) Proc. Natl. Acad. Sci. U.S.A.89, 9924-9928]. To examine effects of these missense mutations onproperties of TNSALP, the TNSALP mutants were expressed ectopically inCOS-1 cells. The wild-type TNSALP was synthesized as a 66-kDa endo-beta-N-acetylglucosaminidase H (Endo H)-sensitive form, and processed to an 80-kDa mature form, which is anchored to the plasma membrane via glycosylphosphatidylinositol (GPI). Although the mutant proteins were found to be modified by GPI, digestion with phosphatidylinositol-specific phospholipase C, cell-surface biotinylation and immunofluorescence observation demonstrated that the cell-surface appearance of TNSALP (R54C) and TNSALP (D277A) was either almost totally or partially retarded respectively. The 66-kDa Endo H-sensitive band was the only form, and was rapidly degraded in the cells expressing TNSALP (R54C). In contrast with cells expressing TNSALP(R54C), where alkaline phosphatase activity was negligible, significant enzyme activity was detected and, furthermore, the 80-kDa mature form appeared on the surface of the cells expressing TNSALP (D277A). Analysis by sedimentation on sucrose gradients showed that a considerable fraction of newly synthesized TNSALP (R54C) and TNSALP(D277A) formed large aggregates, indicating improper folding and incorrect oligomerization of the mutant enzymes. When co-expressed with TNSALP (R54C), the level of the 80-kDa mature form of TNSALP (D277A)was decreased dramatically, with a concomitant reduction in enzyme activity in the co-transfected cell. These findings suggest that TNSALP(R54C) interferes with folding and assembly of TNSALP (D277A) intrans when expressed in the same cell, thus probably explaining why a compound heterozygote for these mutant alleles developed severe hypophosphatasia.
在一名低磷酸酯酶症患者中发现了组织非特异性碱性磷酸酶(TNSALP)存在精氨酸(54)→半胱氨酸(R54C)或天冬氨酸(277)→丙氨酸(D277A)的替换[亨索恩、拉杜查、费德、拉弗蒂和怀特(1992年)《美国国家科学院院刊》89,9924 - 9928]。为了研究这些错义突变对TNSALP特性的影响,将TNSALP突变体在COS - 1细胞中异位表达。野生型TNSALP以一种66 kDa的对内切β - N - 乙酰葡糖胺糖苷酶H(Endo H)敏感的形式合成,并加工成一种80 kDa的成熟形式,该成熟形式通过糖基磷脂酰肌醇(GPI)锚定在质膜上。尽管发现突变蛋白被GPI修饰,但用磷脂酰肌醇特异性磷脂酶C消化、细胞表面生物素化和免疫荧光观察表明,TNSALP(R54C)和TNSALP(D277A)在细胞表面的出现分别几乎完全受阻或部分受阻。66 kDa的Endo H敏感条带是唯一的形式,并且在表达TNSALP(R54C)的细胞中迅速降解。与表达TNSALP(R54C)的细胞不同,在表达TNSALP(R54C)的细胞中碱性磷酸酶活性可忽略不计,而在表达TNSALP(D277A)的细胞表面检测到了显著的酶活性,此外,80 kDa的成熟形式也出现在这些细胞表面。通过在蔗糖梯度上沉降分析表明,相当一部分新合成的TNSALP(R54C)和TNSALP(D277A)形成了大的聚集体,这表明突变酶折叠不当且寡聚化不正确。当与TNSALP(R54C)共表达时,TNSALP(D277A)的80 kDa成熟形式的水平显著降低,同时共转染细胞中的酶活性也随之降低。这些发现表明,当在同一细胞中表达时,TNSALP(R54C)会干扰TNSALP(D277A)的折叠和组装,从而可能解释了为什么这些突变等位基因的复合杂合子会出现严重的低磷酸酯酶症。